Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-10-05
1988-08-09
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3148
Patent
active
047628421
ABSTRACT:
Method of blocking 5HT without effect on alpha receptors with 1-loweralkyl-6-straight chain alkyl-8.beta.-hydroxycycloalkyloxycarbonylergolines.
REFERENCES:
patent: 3113133 (1963-12-01), Hofmann et al.
patent: 3183234 (1965-05-01), Garbrecht et al.
patent: 3228941 (1966-01-01), Bernardi et al.
patent: 3249617 (1966-05-01), Hofmann et al.
patent: 3580916 (1971-05-01), Garbrecht
patent: 4230859 (1980-10-01), Rucman
patent: 4563461 (1986-01-01), Cohen et al.
Cohen, Drug Development Res., 5, 313 (1985), (Cohen IV).
Cohen et al., J.P.E.T., 232, 770 (1985) (Cohen III).
Berde, The Medical Journal of Australia, Special Supplement, Nov. 4, 1978, pp. 3-13.
Franciullacci et al., Headache, 16, 226 (1976).
Calesnick, AFP, 25, 228 (1982).
Awouters, 5-Hydroxytryptamine in Perpheral Reactions (Raven Press, N.Y. 1982), pp. 71-75.
Aellig, Eur. J. Clin. Pharm., 25, 759 (1983).
Sulman et al., Headache, 17, 203 (1979).
Amano et al., ibid, 22, 249 (1982).
Cohen et al., J.P.E.T., 227, 327 (1983), (Cohen I).
Lance, Brit. Med. J., 1970 (2) 327 (Lance I).
Saxena, ibid, 12, 44 (1972).
Lance and Anthony, Proc. Aust. Assoc. Neurol., 7, 32 (1970).
Prusinski et al., Pol. J. Pharmacol. Pharm., 37, Suppl. 189-193.
Harriet F. Lemberger et al., Life Sci., 35, 71 (1984).
Hingten et al., Soc. for Neuroscience Abstract 374, p. 125, (1983).
Cohen Marlene L.
Fuller Ray W.
Garbrecht William L.
Whitten Kathleen R.
Barclay Bruce J.
Eli Lilly and Company
Friedman Stanley J.
Whitaker Leroy
LandOfFree
Selective method for blocking 5HT2 receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Selective method for blocking 5HT2 receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective method for blocking 5HT2 receptors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-918816